Items Tagged with 'generic'


Group Questions Abbott's Agreement With Thai Government

Despite Abbott Laboratories' recent decision to cut the price of one of its HIV drugs in Thailand, an activist group is questioning the drugmaker's "quid pro quo" approach of lowering drug prices in exchange for halting compulsory licensing. Read More

Famvir Ruling Seen as Good News for Generic Companies

The reversal of a U.S. district court’s decision that dismissed a legal action brought by Teva Pharmaceutical to launch generic Famvir may have positive implications for generic firms taking moves to avoid at-risk launches, according to legal sources.

Read More

Court Blocks Early Generic Topamax Launch

Mylan Laboratories lost its bid to launch generic Topamax capsules and tablets after a federal court barred the company from selling its version of the epilepsy treatment prior to late 2008.

Read More